Dendritic cells and acute graft-versus-host disease after allogeneic stem cell transplantation

Leukemia and Lymphoma

Volumn 48, Issue 9, 2007, Pages 1696-1701

  Mohty, Mohamad ^a  

^a INSTITUT PAOLI CALMETTES   (France)

Author keywords

Allogeneic transplant; Dendritic cells; Graft versus host disease

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ACUTE GRAFT VERSUS HOST DISEASE; ADOPTIVE TRANSFER; ALLOGENEIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; ANTIGEN PRESENTING CELL; CD8+ T LYMPHOCYTE; CELL INTERACTION; CELL MATURATION; CELL MIGRATION; CELL SUBPOPULATION; CELLULAR IMMUNITY; CHIMERA; DENDRITIC CELL; DISEASE SEVERITY; DONOR; EFFECTOR CELL; HLA MATCHING; HUMAN; IMMUNOLOGICAL TOLERANCE; INFECTION SENSITIVITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION;

ACUTE DISEASE; DENDRITIC CELLS; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTERFERON TYPE I; TRANSPLANTATION, HOMOLOGOUS;

EID: 34548561912     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701472013     Document Type: Review

References (42)

1. Billingham, R. E. (1966) The biology of graft-versus-host reactions. Harvey Lect, 62, pp. 21-78.
2. Sackstein, R. (2006) A revision of Billingham's tenets: The central role of lymphocyte migration in acute graft-versus-host disease. Biol Blood Marrow Transplant, 12, pp. 2-8.
3. Holler, E., Kolb, H. J., Moller, A., Kempeni, J., Liesenfeld, S. and Pechumer, H. (1990) Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood, 75, pp. 1011-1016.
4. Ferrara, J. L. and Reddy, P. (2006) Pathophysiology of graft-versus-host disease. Semin Hematol, 43, pp. 3-10.
5. Holler, E., Kolb, H. J., Mittermuller, J., Kaul, M., Ledderose, G. and Duell, T. (1995) Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: Role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F). Blood, 86, pp. 890-899.
6. Shlomchik, W. D., Couzens, M. S., Tang, C. B., McNiff, J., Robert, M. E. and Liu, J. (1999) Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science, 285, pp. 412-415.
7. Teshima, T., Ordemann, R., Reddy, P., Gagin, S., Liu, C. and Cooke, K. R. (2002) Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat Med, 8, pp. 575-581.
8. Matte, C. C., Liu, J., Cormier, J., Anderson, B. E., Athanasiadis, I. and Jain, D. (2004) Donor APCs are required for maximal GVHD but not for GVL. Nat Med, 10, pp. 987-992.
9. Mapara, M. Y., Kim, Y. M., Wang, S. P., Bronson, R., Sachs, D. H. and Sykes, M. (2002) Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: A critical role for host antigen-presenting cells. Blood, 100, pp. 1903-1909.
10. Reddy, P., Maeda, Y., Liu, C., Krijanovski, O. I., Korngold, R. and Ferrara, J. L. (2005) A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses. Nat Med, 11, pp. 1244-1249.
11. Mapara, M. Y., Kim, Y. M., Marx, J. and Sykes, M. (2003) Donor lymphocyte infusion-mediated graft-versus-leukemia effects in mixed chimeras established with a nonmyeloablative conditioning regimen: extinction of graft-versus-leukemia effects after conversion to full donor chimerism. Transplantation, 76, pp. 297-305.
12. Ordemann, R., Hutchinson, R., Friedman, J., Burakoff, S. J., Reddy, P. and Duffner, U. (2002) Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease. J Clin Invest, 109, pp. 1249-1256.
13. Banchereau, J. and Steinman, R. M. (1998) Dendritic cells and the control of immunity. Nature, 392, pp. 245-252.
14. van Kooyk, Y. and Geijtenbeek, T. B. (2003) DC-SIGN: Escape mechanism for pathogens. Nat Rev Immunol, 3, pp. 697-709.
15. Sallusto, F. and Lanzavecchia, A. (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med, 179, pp. 1109-1118.
16. Steinman, R. M., Hawiger, D. and Nussenzweig, M. C. (2003) Tolerogenic dendritic cells. Annu Rev Immunol, 21, pp. 685-711.
17. Liu, Y. J. (2005) IPC: Professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol, 23, pp. 275-306.
18. Kuwana, M., Kaburaki, J., Wright, T. M., Kawakami, Y. and Ikeda, Y. (2001) Induction of antigen-specific human CD4(+) T cell anergy by peripheral blood DC2 precursors. Eur J Immunol, 31, pp. 2547-2557.
19. Moseman, E. A., Liang, X., Dawson, A. J., Panoskaltsis-Mortari, A., Krieg, A. M. and Liu, Y. J. (2004) Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J Immunol, 173, pp. 4433-4442.
20. Gilliet, M. and Liu, Y. J. (2002) Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med, 195, pp. 695-704.
21. Colonna, M., Trinchieri, G. and Liu, Y. J. (2004) Plasmacytoid dendritic cells in immunity. Nat Immunol, 5, pp. 1219-1226.
22. Martin, P., Hoyo, G M Del, Anjuere, F., Arias, C. F., Vargas, H. H. and Fernandez, L. A. (2002) Characterization of a new subpopulation of mouse CD8alpha+ B220+ dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential. Blood, 100, pp. 383-390.
23. Bilsborough, J., George, T. C., Norment, A. and Viney, J. L. (2003) Mucosal CD8alpha+ DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties. Immunology, 108, pp. 481-492.
24. de Heer, H. J., Hammad, H., Soullie, T., Hijdra, D., Vos, N. and Willart, M. A. (2004) Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med, 200, pp. 89-98.
25. Mellor, A. L., Baban, B., Chandler, P., Marshall, B., Jhaver, K. and Hansen, A. (2003) Cutting edge: Induced indoleamine 2,3-dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J Immunol, 171, pp. 1652-1655.
26. Fallarino, F., Asselin-Paturel, C., Vacca, C., Bianchi, R., Gizzi, S. and Fioretti, M. C. (2004) Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement. J Immunol, 173, pp. 3748-3754.
27. Salio, M., Palmowski, M. J., Atzberger, A., Hermans, I. F. and Cerundolo, V. (2004) CpG-matured murine plasmacytoid dendritic cells are capable of in vivo priming of functional CD8 T cell responses to endogenous but not exogenous antigens. J Exp Med, 199, pp. 567-579.
28. Schlecht, G., Garcia, S., Escriou, N., Freitas, A. A., Leclerc, C. and Dadaglio, G. (2004) Murine plasmacytoid dendritic cells induce effector/ memory CD8+ T-cell responses in vivo after viral stimulation. Blood, 104, pp. 1808-1815.
29. Ochando, J. C., Homma, C., Yang, Y., Hidalgo, A., Garin, A. and Tacke, F. (2006) Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat Immunol, 7, pp. 652-662.
30. Benitez-Ribas, D., Adema, G. J., Winkels, G., Klasen, I. S., Punt, C. J. and Figdor, C. G. (2006) Plasmacytoid dendritic cells of melanoma patients present exogenous proteins to CD4+ T cells after Fc gamma RII-mediated uptake. J Exp Med, 203, pp. 1629-1635.
31. Waller, E. K., Rosenthal, H., Jones, T. W., Peel, J., Lonial, S. and Langston, A. (2001) Larger numbers of CD4(bright) dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation. Blood, 97, pp. 2948-2956.
32. Arpinati, M., Green, C. L., Heimfeld, S., Heuser, J. E. and Anasetti, C. (2000) Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood, 95, pp. 2484-2490.
33. Fagnoni, F. F., Oliviero, B., Giorgiani, G., De Stefano, P., Deho, A. and Zibera, C. (2004) Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic myeloablative hematopoietic stem cell transplantation. Blood, 104, pp. 281-289.
34. Chklovskaia, E., Nowbakht, P., Nissen, C., Gratwohl, A., Bargetzi, M. and Wodnar-Filipowicz, A. (2004) Reconstitution of dendritic and natural killer-cell subsets after allogeneic stem cell transplantation: Effects of endogenous flt3 ligand. Blood, 103, pp. 3860-3868.
35. Mohty, M., Blaise, D., Faucher, C., Bardou, V. J., Gastaut, J. A. and Viens, P. (2005) Impact of plasmacytoid dendritic cells on outcome after reduced-intensity conditioning allogeneic stem cell transplantation. Leukemia, 19, pp. 1-6.
36. Reddy, V., Iturraspe, J. A., Tzolas, A. C., Meier-Kriesche, H. U. and Schold, J. (2004) Low dendritic cell count after allogeneic hematopoietic stem cell transplantation predicts relapse, death, and acute graft-versus-host disease. Blood, 103, pp. 4330-4335.
37. Vakkila, J., Thomson, A. W., Hovi, L., Vettenranta, K. and Saarinen-Pihkala, U. M. (2005) Circulating dendritic cell subset levels after allogeneic stem cell transplantation in children correlate with time post transplant and severity of acute graft-versus-host disease. Bone Marrow Transplant, 35, pp. 501-507.
38. Arpinati, M., Chirumbolo, G., Urbini, B., Bonifazi, F., Bandini, G. and Saunthararajah, Y. (2004) Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation. Biol Blood Marrow Transplant, 10, pp. 106-115.
39. Kitawaki, T., Kadowaki, N., Ishikawa, T., Ichinohe, T. and Uchiyama, T. (2003) Compromised recovery of natural interferon-alpha/beta-producing cells after allogeneic hematopoietic stem cell transplantation complicated by acute graft-versus-host disease and glucocorticoid administration. Bone Marrow Transplant, 32, pp. 187-194.
40. Clark, F. J., Freeman, L., Dzionek, A., Schmitz, J., McMullan, D. and Simpson, P. (2003) Origin and subset distribution of peripheral blood dendritic cells in patients with chronic graft-versus-host disease. Transplantation, 75, pp. 221-225.
41. Lau, J., Sartor, M., Bradstock, K. F., Vuckovic, S., Munster, D. J. and Hart, D. N. (2007) Activated circulating dendritic cells after hematopoietic stem cell transplantation predict acute graft-versus-host disease. Transplantation, 83, pp. 839-846.
42. Collin, M. P., Hart, D. N., Jackson, G. H., Cook, G., Cavet, J. and Mackinnon, S. (2006) The fate of human Langerhans cells in hematopoietic stem cell transplantation. J Exp Med, 203, pp. 27-33.